The future paradigm of AI-driven RNA drug development (IMAGE)

Higher Education Press

The future paradigm of AI-driven RNA drug development

Caption

(a) Success rate, timeline, and cost (in billions) of traditional drug development versus RNA drug development, along with a description of the evolutionary progress of the latter. (b) The future paradigm of AI-driven RNA drug development, characterized by interactive software and a closed loop of upstream drug design and downstream application. PD/PK: pharmacodynamics/pharmacokinetics; MFE: molecular free energy.

Credit

Yilin Yan, Tianyu Wu, Honglin Li, Yang Tang, Feng Qian

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.

License

CC BY-NC-ND

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.